Lifevantage (NASDAQ:LFVN) Announces Quarterly Earnings Results

Lifevantage (NASDAQ:LFVN) issued its earnings results on Monday. The company reported $0.05 earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.01), FiscalAI reports. The firm had revenue of $37.12 million for the quarter, compared to the consensus estimate of $40.49 million. Lifevantage had a net margin of 2.78% and a return on equity of 21.56%.

Here are the key takeaways from Lifevantage’s conference call:

• Revenue and earnings fell sharply: First-quarter revenue declined 22% year over year to $37.1 million as orders and average order size decreased. Adjusted EBITDA fell to $1.9 million from $3.9 million, and the company reported a GAAP operating loss.
• Management laid out a broad transformation plan focused on repositioning the brand, improving the digital consumer experience, and making the business more efficient. Planned launches include a new North American website and digital platform in calendar Q2 2027, followed by seller tools in Q3.
• The company has a solid financial cushion: It ended the quarter with $13.7 million in cash, no debt, and $0.5 million in cash from operations. Management said it expects operating cash flow to remain positive.
• Subscription-based sales represented more than 75% of revenue, and management reported improved customer and consultant retention compared with the prior-year quarter. However, the company is not providing formal guidance while it works through its strategy and fiscal-year transition.

Lifevantage Price Performance

Shares of NASDAQ LFVN opened at $5.29 on Tuesday. Lifevantage has a 1-year low of $3.90 and a 1-year high of $11.71. The business has a fifty day moving average price of $6.04 and a 200 day moving average price of $5.88. The stock has a market capitalization of $66.60 million, a P/E ratio of 13.22 and a beta of 0.71.

Lifevantage Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Tuesday, December 1st will be paid a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a dividend yield of 3.8%. The ex-dividend date is Tuesday, December 1st. Lifevantage’s dividend payout ratio is 50.00%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Lake Street Capital increased their price target on Lifevantage from $5.00 to $6.00 and gave the stock a “hold” rating in a research report on Friday, August 28th. Zacks Research downgraded Lifevantage from a “hold” rating to a “strong sell” rating in a report on Friday, October 16th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Lifevantage in a research note on Friday, August 21st. Two investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus target price of $5.50.

Insider Transactions at Lifevantage

In other Lifevantage news, insider Kristen Cunningham sold 8,901 shares of the business’s stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $6.18, for a total value of $55,008.18. Following the completion of the transaction, the insider directly owned 120,162 shares in the company, valued at approximately $742,601.16. The trade was a 6.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 13.58% of the stock is owned by company insiders.

Lifevantage Company Profile

LifeVantage Corporation is a health and wellness company that develops, markets and distributes dietary supplements and personal-care products. Its product portfolio is designed to support areas such as cellular health, antioxidant defenses, energy, nutrition and skin care.

The company’s principal brands have included Protandim, a line of dietary supplements; TrueScience, a skin-care and wellness brand; and Petandim, products formulated for pets. LifeVantage primarily uses a direct-selling business model, distributing its products through independent sales representatives and online channels.

Founded in 2003 and headquartered in Lehi, Utah, LifeVantage serves customers in the United States and selected international markets.